EUVIMEDEUVIMED entdecken
Crossref

Application of mass cytometry in multiparametric characterization of precancerous cervical lesions

Ena Pešut iD, Ivana Šimić iD, Daniela Kužilkova iD, Tomáš Kalina iD, Rajko Fureš iD, Ivana Erceg Ivkošić iD, Nina Milutin Gašperov iD, Ivan Sabol iD

Cytometry Part B: Clinical Cytometry · 2025

DOI: 10.1002/cyto.b.22211 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cytometry Part B: Clinical Cytometry, 2025. Verfasst von Ena Pešut und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular Medicine, Ruđer Bošković Institute, Zagreb, Croatia. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Precancerous Conditions, Flow Cytometry. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: Hrvatska Zaklada za Znanost.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cervical cancer (CC) is the fourth most common malignant tumor in women worldwide. Detecting different biomarkers together on single cells by novel method mass cytometry could contribute to more precise screening. Liquid‐based cytology (LBC) cervical samples were collected ( N = 53) from women categorized as normal and precancerous lesions. Human papillomavirus was genotyped by polymerase chain reaction, while simultaneous examination of the expression of 29 proteins was done by mass cytometry (CyTOF). Differences in cluster abundances were assessed with Spearman's rank correlation as well as high dimensional data analysis (t‐SNE, FlowSOM). Cytokeratin (ITGA6, Ck5, Ck10/13, Ck14, Ck7) expression patterns allowed determining the presence of different cells in the cervical epithelium. FlowSOM analysis enabled to phenotype cervical cells in five different metaclusters and find new markers that could be important in CC screening. The markers Ck18, Ck18, and CD63 (Metacluster 3) showed significantly increasing associated with severity of the precancerous lesions (Spearman rank correlation rho 0.304, p = 0.0271), while CD71, KLF4, LRIG1, E‐cadherin, Nanog and p53 (Metacluster 1) decreased with severity of the precancerous lesions (Spearman rank correlation rho −0.401, p = 0.0029). Other metaclusters did not show significant correlation, but metacluster 2 (Ck17, MCM, MMP7, CD29, E‐cadherin, Nanog, p53) showed higher abundance in low‐ and high‐grade intraepithelial lesion cases. CyTOF appears feasible and should be considered when examining novel biomarkers on cervical LBC samples. This study enabled us to characterize different cells in the cervical epithelium and find markers and populations that could distinguish precancerous lesions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsPrecancerous ConditionsFlow CytometryHumansFemaleKruppel-Like Factor 4AdultBiomarkers, TumorMiddle AgedPapillomavirus InfectionsCervix UteriUterine Cervical DysplasiaKeratinsPapillomaviridae

Stichwörter der Autor:innen

HPVcervical cancermarkersmass cytometry

Substanzen

Kruppel-Like Factor 4Biomarkers, TumorKLF4 protein, humanKeratins

Autor:innen und Institutionen

  • Division of Molecular Medicine, Ruđer Bošković Institute, Zagreb, Croatia.
  • CLIP-Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czechia.
  • General Hospital Zabok and Veterans Affairs Hospital, Department of Gynecology and Obstetrics, Zabok, Croatia.
  • Faculty of Dental Medicine and Health, Josip Juraj Strossmayer University Osijek, Osijek, Croatia.
  • Special Hospital Sveta Katarina, Department of Women's Health, Zagreb, Croatia.

ORCID-Profile: Ena Pešut, Ivana Šimić, Daniela Kužilkova, Tomáš Kalina, Rajko Fureš, Ivana Erceg Ivkošić, Nina Milutin Gašperov, Ivan Sabol

Förderung

  • Hrvatska Zaklada za Znanost

Zitieren

APA

Pešut, E., Šimić, I., Kužilkova, D., Kalina, T., Fureš, R., Erceg Ivkošić, I., Milutin Gašperov, N., & Sabol, I. (2025). Application of mass cytometry in multiparametric characterization of precancerous cervical lesions. Cytometry Part B: Clinical Cytometry. https://doi.org/10.1002/cyto.b.22211

Vancouver

Pešut E, Šimić I, Kužilkova D, Kalina T, Fureš R, Erceg Ivkošić I, et al. Application of mass cytometry in multiparametric characterization of precancerous cervical lesions. Cytometry Part B: Clinical Cytometry. 2025. doi:10.1002/cyto.b.22211

BibTeX
@article{Peut2025,
  author = {Pešut, Ena and Šimić, Ivana and Kužilkova, Daniela and Kalina, Tomáš and Fureš, Rajko and Erceg Ivkošić, Ivana and Milutin Gašperov, Nina and Sabol, Ivan},
  title = {Application of mass cytometry in multiparametric characterization of precancerous cervical lesions},
  journal = {Cytometry Part B: Clinical Cytometry},
  year = {2025},
  doi = {10.1002/cyto.b.22211}
}
Kostenlos starten →